COLGATE-PALMOLIVE COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34,655 ARS | +0.61% |
|
+2.16% | +32.86% |
| 16/05 | Colgate Palmolive Insider Sold Shares Worth $2,094,940, According to a Recent SEC Filing | MT |
| 15/05 | Argus Raises Price Target on Colgate-Palmolive to $107 From $97 | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With a 2024 P/E ratio at 26.93 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company's enterprise value to sales, at 4.2 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Sector: Personal Products
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +32.86% | 77.56B | - | ||
| +14.56% | 396B | C- | ||
| +13.58% | 142B | B- | ||
| -12.91% | 65.94B | A- | ||
| -4.32% | 43.2B | - | ||
| +6.45% | 35.03B | B- | ||
| +11.20% | 18.17B | A- | ||
| +14.49% | 15.96B | B | ||
| -3.84% | 11.51B | C+ | ||
| +6.05% | 8.75B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CL Stock
- CL Stock
- Ratings Colgate-Palmolive Company